Chemoinformaics analysis of 3,4,5-TRI-O-CAFFEOYLQUINIC-ACID
| Molecular Weight | 678.599 | nRot | 10 |
| Heavy Atom Molecular Weight | 648.359 | nRig | 31 |
| Exact Molecular Weight | 678.158 | nRing | 4 |
| Solubility: LogS | -3.087 | nHRing | 0 |
| Solubility: LogP | 3.081 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 49 | No. of Aromatic Carbocycles | 3 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 18 |
| nHA | 14 | APOL | 88.8138 |
| nHD | 8 | BPOL | 38.7762 |
| QED | 0.066 |
| Synth | 4.073 |
| Natural Product Likeliness | 1.05 |
| NR-PPAR-gamma | 0.929 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.295 |
| HIA | 0.942 |
| CACO-2 | -6.321 |
| MDCK | 0.000014 |
| BBB | 0.018 |
| PPB | 0.989109 |
| VDSS | 0.376 |
| FU | 0.0123957 |
| CYP1A2-inh | 0.198 |
| CYP1A2-sub | 0.015 |
| CYP2c19-inh | 0.204 |
| CYP2c19-sub | 0.04 |
| CYP2c9-inh | 0.443 |
| CYP2c9-sub | 0.153 |
| CYP2d6-inh | 0.128 |
| CYP2d6-sub | 0.136 |
| CYP3a4-inh | 0.053 |
| CYP3a4-sub | 0.128 |
| CL | 5.172 |
| T12 | 0.961 |
| hERG | 0.071 |
| Ames | 0.037 |
| ROA | 0.113 |
| SkinSen | 0.965 |
| Carcinogencity | 0.204 |
| EI | 0.543 |
| Respiratory | 0.019 |
| NR-Aromatase | 0.658 |
| Antiviral | Yes |
| Prediction | 0.853969 |